α-Smooth muscle actin expressing stroma promotes an aggressive tumor biology in pancreatic ductal adenocarcinoma

Hayato Fujita, Kenoki Ohuchida, Kazuhiro Mizumoto, Kohei Nakata, Jun Yu, Tadashi Kayashima, Lin Cui, Tatsuya Manabe, Takao Ohtsuka, Masao Tanaka

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Objectives: Pancreatic ductal adenocarcinoma (PDAC) is often characterized by a prominent desmoplastic stroma that is induced partially by α-smooth muscle actin (SMA)-expressing activated pancreatic stellate cells (PSCs). This study aimed to investigate the significance of α-SMA expression in PDAC and the correlation between α-SMA mRNA levels and the patient prognosis. Methods: We obtained formalin-fixed, paraffin-embedded tissue samples from 109 patients with PDAC, who underwent pancreatectomy at our institution from 1992 to 2007. We measured α-SMA mRNA levels by quantitative real-time reverse transcription-polymerase chain reaction and investigated the association of α-SMA mRNA expression with clinicopathologic parameters and survival time. We also assessed the influence of activated PSCs on malignant behaviors of pancreatic cancer cells using in vitro experiments. Results: α-SMA immunoreactivity was detected exclusively in the stroma of PDAC. The group with high α-SMA expression showed a significantly shorter survival, as shown by univariate analysis (P = 0.005) and multivariate analysis (P < 0.0001). α-SMA-expressing activated PSCs enhanced the invasiveness, proliferation, and colony formation of pancreatic cancer cells. Conclusions: Quantitative analysis of α-SMA mRNA expression using formalin-fixed, paraffin-embedded tissue samples was useful to predict the prognosis of patients with PDAC. Activated PSCs may regulate the malignant behavior of pancreatic cancer cells.

Original languageEnglish
Pages (from-to)1254-1262
Number of pages9
JournalPancreas
Volume39
Issue number8
DOIs
Publication statusPublished - Nov 1 2010

Fingerprint

Smooth Muscle
Actins
Adenocarcinoma
Pancreatic Stellate Cells
Neoplasms
Pancreatic Neoplasms
Messenger RNA
Paraffin
Formaldehyde
Pancreatectomy
Survival
Reverse Transcription
Multivariate Analysis
Polymerase Chain Reaction

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Endocrinology

Cite this

α-Smooth muscle actin expressing stroma promotes an aggressive tumor biology in pancreatic ductal adenocarcinoma. / Fujita, Hayato; Ohuchida, Kenoki; Mizumoto, Kazuhiro; Nakata, Kohei; Yu, Jun; Kayashima, Tadashi; Cui, Lin; Manabe, Tatsuya; Ohtsuka, Takao; Tanaka, Masao.

In: Pancreas, Vol. 39, No. 8, 01.11.2010, p. 1254-1262.

Research output: Contribution to journalArticle

@article{3619e8c46c0840d598cae24cc2d292b9,
title = "α-Smooth muscle actin expressing stroma promotes an aggressive tumor biology in pancreatic ductal adenocarcinoma",
abstract = "Objectives: Pancreatic ductal adenocarcinoma (PDAC) is often characterized by a prominent desmoplastic stroma that is induced partially by α-smooth muscle actin (SMA)-expressing activated pancreatic stellate cells (PSCs). This study aimed to investigate the significance of α-SMA expression in PDAC and the correlation between α-SMA mRNA levels and the patient prognosis. Methods: We obtained formalin-fixed, paraffin-embedded tissue samples from 109 patients with PDAC, who underwent pancreatectomy at our institution from 1992 to 2007. We measured α-SMA mRNA levels by quantitative real-time reverse transcription-polymerase chain reaction and investigated the association of α-SMA mRNA expression with clinicopathologic parameters and survival time. We also assessed the influence of activated PSCs on malignant behaviors of pancreatic cancer cells using in vitro experiments. Results: α-SMA immunoreactivity was detected exclusively in the stroma of PDAC. The group with high α-SMA expression showed a significantly shorter survival, as shown by univariate analysis (P = 0.005) and multivariate analysis (P < 0.0001). α-SMA-expressing activated PSCs enhanced the invasiveness, proliferation, and colony formation of pancreatic cancer cells. Conclusions: Quantitative analysis of α-SMA mRNA expression using formalin-fixed, paraffin-embedded tissue samples was useful to predict the prognosis of patients with PDAC. Activated PSCs may regulate the malignant behavior of pancreatic cancer cells.",
author = "Hayato Fujita and Kenoki Ohuchida and Kazuhiro Mizumoto and Kohei Nakata and Jun Yu and Tadashi Kayashima and Lin Cui and Tatsuya Manabe and Takao Ohtsuka and Masao Tanaka",
year = "2010",
month = "11",
day = "1",
doi = "10.1097/MPA.0b013e3181dbf647",
language = "English",
volume = "39",
pages = "1254--1262",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - α-Smooth muscle actin expressing stroma promotes an aggressive tumor biology in pancreatic ductal adenocarcinoma

AU - Fujita, Hayato

AU - Ohuchida, Kenoki

AU - Mizumoto, Kazuhiro

AU - Nakata, Kohei

AU - Yu, Jun

AU - Kayashima, Tadashi

AU - Cui, Lin

AU - Manabe, Tatsuya

AU - Ohtsuka, Takao

AU - Tanaka, Masao

PY - 2010/11/1

Y1 - 2010/11/1

N2 - Objectives: Pancreatic ductal adenocarcinoma (PDAC) is often characterized by a prominent desmoplastic stroma that is induced partially by α-smooth muscle actin (SMA)-expressing activated pancreatic stellate cells (PSCs). This study aimed to investigate the significance of α-SMA expression in PDAC and the correlation between α-SMA mRNA levels and the patient prognosis. Methods: We obtained formalin-fixed, paraffin-embedded tissue samples from 109 patients with PDAC, who underwent pancreatectomy at our institution from 1992 to 2007. We measured α-SMA mRNA levels by quantitative real-time reverse transcription-polymerase chain reaction and investigated the association of α-SMA mRNA expression with clinicopathologic parameters and survival time. We also assessed the influence of activated PSCs on malignant behaviors of pancreatic cancer cells using in vitro experiments. Results: α-SMA immunoreactivity was detected exclusively in the stroma of PDAC. The group with high α-SMA expression showed a significantly shorter survival, as shown by univariate analysis (P = 0.005) and multivariate analysis (P < 0.0001). α-SMA-expressing activated PSCs enhanced the invasiveness, proliferation, and colony formation of pancreatic cancer cells. Conclusions: Quantitative analysis of α-SMA mRNA expression using formalin-fixed, paraffin-embedded tissue samples was useful to predict the prognosis of patients with PDAC. Activated PSCs may regulate the malignant behavior of pancreatic cancer cells.

AB - Objectives: Pancreatic ductal adenocarcinoma (PDAC) is often characterized by a prominent desmoplastic stroma that is induced partially by α-smooth muscle actin (SMA)-expressing activated pancreatic stellate cells (PSCs). This study aimed to investigate the significance of α-SMA expression in PDAC and the correlation between α-SMA mRNA levels and the patient prognosis. Methods: We obtained formalin-fixed, paraffin-embedded tissue samples from 109 patients with PDAC, who underwent pancreatectomy at our institution from 1992 to 2007. We measured α-SMA mRNA levels by quantitative real-time reverse transcription-polymerase chain reaction and investigated the association of α-SMA mRNA expression with clinicopathologic parameters and survival time. We also assessed the influence of activated PSCs on malignant behaviors of pancreatic cancer cells using in vitro experiments. Results: α-SMA immunoreactivity was detected exclusively in the stroma of PDAC. The group with high α-SMA expression showed a significantly shorter survival, as shown by univariate analysis (P = 0.005) and multivariate analysis (P < 0.0001). α-SMA-expressing activated PSCs enhanced the invasiveness, proliferation, and colony formation of pancreatic cancer cells. Conclusions: Quantitative analysis of α-SMA mRNA expression using formalin-fixed, paraffin-embedded tissue samples was useful to predict the prognosis of patients with PDAC. Activated PSCs may regulate the malignant behavior of pancreatic cancer cells.

UR - http://www.scopus.com/inward/record.url?scp=78049317974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78049317974&partnerID=8YFLogxK

U2 - 10.1097/MPA.0b013e3181dbf647

DO - 10.1097/MPA.0b013e3181dbf647

M3 - Article

AN - SCOPUS:78049317974

VL - 39

SP - 1254

EP - 1262

JO - Pancreas

JF - Pancreas

SN - 0885-3177

IS - 8

ER -